Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1247305.RANfG7QzMTl0hQSLZscDvrLnd4M16HW4qQbG7udmH4EAM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1247305.RANfG7QzMTl0hQSLZscDvrLnd4M16HW4qQbG7udmH4EAM130_assertion type Assertion NP1247305.RANfG7QzMTl0hQSLZscDvrLnd4M16HW4qQbG7udmH4EAM130_head.
- NP1247305.RANfG7QzMTl0hQSLZscDvrLnd4M16HW4qQbG7udmH4EAM130_assertion description "[Hepatic KLF2 overexpression was associated with lower portal pressure (-15%) due to both attenuations in the increased portal blood flow and hepatic vascular resistance, together with a significant improvement in hepatic endothelial dysfunction.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1247305.RANfG7QzMTl0hQSLZscDvrLnd4M16HW4qQbG7udmH4EAM130_provenance.
- NP1247305.RANfG7QzMTl0hQSLZscDvrLnd4M16HW4qQbG7udmH4EAM130_assertion evidence source_evidence_literature NP1247305.RANfG7QzMTl0hQSLZscDvrLnd4M16HW4qQbG7udmH4EAM130_provenance.
- NP1247305.RANfG7QzMTl0hQSLZscDvrLnd4M16HW4qQbG7udmH4EAM130_assertion SIO_000772 25500203 NP1247305.RANfG7QzMTl0hQSLZscDvrLnd4M16HW4qQbG7udmH4EAM130_provenance.
- NP1247305.RANfG7QzMTl0hQSLZscDvrLnd4M16HW4qQbG7udmH4EAM130_assertion wasDerivedFrom befree-2016 NP1247305.RANfG7QzMTl0hQSLZscDvrLnd4M16HW4qQbG7udmH4EAM130_provenance.
- NP1247305.RANfG7QzMTl0hQSLZscDvrLnd4M16HW4qQbG7udmH4EAM130_assertion wasGeneratedBy ECO_0000203 NP1247305.RANfG7QzMTl0hQSLZscDvrLnd4M16HW4qQbG7udmH4EAM130_provenance.